Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients: Study Dr. Kamal Kant Kohli13 May 2025 7:00 AM ISTDifferentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those...
Diabetes drug as a possible treatment for prostate cancer, reveals research Dr. Kamal Kant Kohli12 May 2025 9:15 PM ISTAn international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as...
FDA Approves At-Home Cervical Cancer Screening Device Dr. Kamal Kant Kohli12 May 2025 8:30 PM ISTThe US Food and Drug Administration (FDA) has Approved first and only self-collection At-Home Cervical Cancer Screening Device. Patients can now...
Combination of significant weight gain and late motherhood greatly increases woman's risk of breast cancer, finds UK study Dr. Kamal Kant Kohli12 May 2025 2:00 AM ISTWomen who experience significant weight gain after the age of 20 and either have their first child after the age of 30 or don't have children are...
Triple therapy slows glioblastoma growth and extends survival in preclinical study Dr. Kamal Kant Kohli11 May 2025 8:15 PM ISTA new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy...
Johnson & Johnson Medtech, Qure.ai partner to enhance early detection of lung cancer in India Ruchika Sharma11 May 2025 11:00 AM ISTMumbai: Johnson & Johnson MedTech has onboarded Qure.ai as a strategic partner with Johnson & Johnson Private Limited, a Johnson &...
FDA Grants First-Ever Approval for KRAS-Mutated Recurrent Ovarian Cancer Treatment Dr. Kamal Kant Kohli9 May 2025 8:15 PM ISTThe FDA has granted accelerated approval to the combination therapy of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for adults with...
Exercise can counter detrimental effects of cancer treatment Dr. Kamal Kant Kohli9 May 2025 8:15 PM ISTExercise can counter the detrimental effects of cancer treatment, such as heart and nerve damage and brain fog, suggests an overarching review of the...
AstraZeneca Pharma India gets CDSCO approval for Enhertu for new breast cancer indication Ruchika Sharma9 May 2025 3:31 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali Deeksha Bhandari9 May 2025 12:00 PM ISTCancer and chemotherapy-induced anemia (CIA) is a common complication in patients undergoing active chemotherapy, with or without radiation therapy....
Blood test for many cancers could potentially thwart progression to late stage in up to half of cases: Study Dr. Kamal Kant Kohli9 May 2025 5:00 AM ISTA single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart...
One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment, suggests study Dr. Kamal Kant Kohli8 May 2025 9:15 PM ISTPresented at ESTRO 2025, which gathered a record attendance of 7,908 participants this week in Vienna, Austria, a 10-year study, involving over 4,000...
